NEO Program Receives FISPE Grant
UAMS and UNM's Nuclear Education
Online program
was awarded a
coveted Fund for the Improvement of Postsecondary Education (FIPSE)
Award. This is
a very competitive and prestigious award, which is funded by the
U.S. Dept. of Education. The $440,861 grant will run three
years, and will assist in the expansion of the
NEO program into
nuclear cardiology and PET education. NEO will also serve as an
educational model for specialized fields of study.
For more information...
- Nuclear Education Faculty
Position
- The University of Arkansas for
Medical Sciences is searching for a new faculty member to serve as
project manager for the expansion of the NEO program. This
is a great career opportunity!
For more information...
-
- Imaging Source Consortium
- Berlex, Bracco Diagnostics, E-Z-EM,
and PETNet Solutions have formed Imaging Choice Consortium, an
alliance aimed at providing customers with a range of imaging
contrast agents in one purchasing portfolio.
For more information...
-
- Nuclear Medicine Week
- Don't forget that October 3-9,
2004 is designated as Nuclear Medicine Week. Celebrate the
many advances that have, over the years, transformed what was once
deemed 'UnClear' medicine into today's 'NuClear' medicine.


- © 2004 Nuclear Education Online
- 4301 W. Markham #522
- Little Rock, AR 72205
- 501-686-6398
- For more information, contact
Nicki Hilliard
|
|

|
Radiation Hormesis?
It is a general belief that low doses of ionizing
radiation produce detrimental effects proportional
to the effects produced by high-level radiation.
Over the past decades, however, some pioneer
scientists have reported that low-dose ionizing
radiation is not only a harmless agent but often
has a beneficial or hormetic effect. the body
responds to radiation by activating repair
mechanisms. Supposedly, the activation of these
repair mechanisms causes us to become more
effective in dealing with the consequences of free
radicals.
[Luckey T. D.,
Radiation Hormesis, CRC Press, Boca Raton, 1991.] |
|
| |


A 56 year old woman with a history of
breast cancer treated with the SWOG chemotherapy regimen and
tamoxifen is evaluated for disease recurrence.
Continued....
- To subscribe to this mailing list
click here.
- To view
previous
issues
If this email does not view graphics
properly go to
http://www.nuclearonline.org/newsletter/Sept04.htm -
-
|